Brimonidine 45802-0078-30

Package NDC

45802-0078-30

Manufacturer: Padagis Israel Pharmaceuticals Ltd
Dosage Form: Gel
Route: Topical
Product Type: Human Prescription Drug
Marketing Start: January 1, 2023
Listing Expires: December 31, 2026
Application: ANDA209158

Need to source Brimonidine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Brimonidine Tartrate	5 mg/g

Drug Class

Adrenergic alpha-Agonists [MoA]alpha-Adrenergic Agonist [EPC]

Selected Package

45802-0078-30Selected

1 BOTTLE, PUMP in 1 CARTON (45802-078-30) / 30 g in 1 BOTTLE, PUMP